Commentary
The prevalence of NAFLD in heart failure preserved left ventricular ejection fraction (HFpEF) patients could reach 50%. Therefore, NAFLD is considered an emerging risk factor.
The purpose of this review by R. Itier et al. (Department of Cardiology, CHU, Toulouse, France) is to provide an overview of the relationships between NAFLD and HFpEF and to discuss its impact in clinical setting.
NAFLD and HFpEF share common risk factors, co-morbidities, and cardiac outcomes, in favour of a pathophysiological continuum. Identifying HF patients at risk of NAFLD is a critically important issue. As soon as NAFLD is confirmed and its severity determined, patients should be proposed a management focused on symptoms and co-morbidities.
